ARCHIVES

Steven Woolf: Why CMS Should Not Cover LDCT

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

ASCO Honors Community Practices For Trial Participation.

June 1, 2007

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012